News – Page 1054 – Endpoints News

SIGN UP

Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event

8 years ago

A week of UK deals exemplifies China’s growing role in global biotech investment

8 years ago

Seattle Genetics seeds a new immuno-oncology collaboration with the protein explorers at Pieris

8 years ago

Scientists toss another Alzheimer’s program into the scrap heap as PhII fails

8 years ago

Sage seeks $575M in public offering; Pfizer inks discovery pact with Chinese firm

8 years ago

GV-backed startup Rani gets $53M from new investors for 'robotic pill'

8 years ago

In latest blow to Teva, CGRP migraine med could be delayed while rivals race towards the finish line

8 years ago

Madrigal touts a mid-stage success in HeFH, cutting bad cholesterol in a competitive field

8 years ago

Genomics meets blockchain: Harvard team featuring George Church launches peer-to-peer genome sequencing startup

8 years ago

No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging

8 years ago

Gilead gets a blockbuster boost from an FDA OK of HIV triplet Biktarvy — and rival GSK fires back

8 years ago

Case Western/Sangamo get $11M grant to wipe out HIV; Sage's depression drug, GSK's vaccine get breakthrough therapy ...

8 years ago

Verastem takes AbbVie’s blood cancer castoff to the FDA

8 years ago

Sanofi sounds taps on a half dozen drug programs in latest pipeline cleanup

8 years ago

Biogen scuttles a Tysabri program after the drug fails stroke test, thinning the pipeline

8 years ago

North of a billion biotech VC dollars to come from C-Bridge, Rothschild as global biopharma capital flows

8 years ago

J&J antes up on a $1B gamble that Theravance has the next blockbuster JAK for Crohn’s, ulcerative colitis

8 years ago

Secret meetings, mergers and a board putsch: Arcturus founder/CEO claims 4 board members conspired on his ouster

8 years ago

Taking on lousy side effects of existing meds, NEA-backed Xoc tackles Parkinson’s/migraines with $30M Series A

8 years ago

Nessan Bermingham returns to VC life; Sanofi's generics unit gets two industry bidders in EMS and Torrent Pharma

8 years ago

Array MEK/BRAF combo beats out Roche rival in PhIII melanoma OS showdown

8 years ago

Eyeing a blockbuster migraine market, Allergan takes an inside track on acute cases with positive PhIII

8 years ago

Zogenix wins inside track at FDA with childhood epilepsy ‘breakthrough’

8 years ago

The Endpoints 100: Biotech execs stampede into 2018 with a cheer for the FDA and bullish feelings on public markets, ...

8 years ago

First page Previous page 1051 1052 105310541055 1056 1057 Next page Last page